Disease | ischemic stroke |
Phenotype | C1861784|cerebral cavernous malformations |
Sentences | 1 |
PubMedID- 24788970 | Background and purpose: data on safety of intravenous thrombolysis with recombinant tissue-type plasminogen activator for acute ischemic stroke in patients with coexisting cerebral cavernous malformations (ccms) are scarce. |
Page: 1